Cargando…

Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015

Screening asylum seekers for infectious diseases is widely performed, but economic evaluations of such are scarce. We performed a policy analysis and economic evaluation of such screening in Germany, and analysed the effect of screening policies on cost differences between federal states. Of the 16...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozorgmehr, Kayvan, Wahedi, Katharina, Noest, Stefan, Szecsenyi, Joachim, Razum, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710125/
https://www.ncbi.nlm.nih.gov/pubmed/29019315
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.40.16-00677
_version_ 1783282918856065024
author Bozorgmehr, Kayvan
Wahedi, Katharina
Noest, Stefan
Szecsenyi, Joachim
Razum, Oliver
author_facet Bozorgmehr, Kayvan
Wahedi, Katharina
Noest, Stefan
Szecsenyi, Joachim
Razum, Oliver
author_sort Bozorgmehr, Kayvan
collection PubMed
description Screening asylum seekers for infectious diseases is widely performed, but economic evaluations of such are scarce. We performed a policy analysis and economic evaluation of such screening in Germany, and analysed the effect of screening policies on cost differences between federal states. Of the 16 states, screening was compulsory for tuberculosis (TB) in asylum seekers ≥ 16 years of age in all states as well as in children < 16 years of age and pregnant women in six states, hepatitis B and enteropathogens in three, syphilis in two and human immunodeficiency virus (HIV) in one state. Of 441,899 asylum seekers, 88.0% were screened for TB, 22.9% for enteropathogens, 16.9% for hepatitis B, 13.1% for syphilis and 11.3% for HIV. The total costs for compulsory screening in 2015 were 10.3 million euros (EUR). Costs per case were highest for infections with Shigella spp. (80,200 EUR), Salmonella spp. (8,000 EUR), TB in those ≥ 16 years of age (5,300 EUR) and syphilis (1,150 EUR). States with extended screening had per capita costs 2.84 times those of states that exclusively screened for TB in asylum seekers ≥ 16 years of age (p < 0.0001, 95% confidence interval (CI): 1.96–4.10). Screening practices in Germany entailed high costs; evidence-based approaches to infectious disease screening are needed.
format Online
Article
Text
id pubmed-5710125
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-57101252017-12-07 Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015 Bozorgmehr, Kayvan Wahedi, Katharina Noest, Stefan Szecsenyi, Joachim Razum, Oliver Euro Surveill Research Article Screening asylum seekers for infectious diseases is widely performed, but economic evaluations of such are scarce. We performed a policy analysis and economic evaluation of such screening in Germany, and analysed the effect of screening policies on cost differences between federal states. Of the 16 states, screening was compulsory for tuberculosis (TB) in asylum seekers ≥ 16 years of age in all states as well as in children < 16 years of age and pregnant women in six states, hepatitis B and enteropathogens in three, syphilis in two and human immunodeficiency virus (HIV) in one state. Of 441,899 asylum seekers, 88.0% were screened for TB, 22.9% for enteropathogens, 16.9% for hepatitis B, 13.1% for syphilis and 11.3% for HIV. The total costs for compulsory screening in 2015 were 10.3 million euros (EUR). Costs per case were highest for infections with Shigella spp. (80,200 EUR), Salmonella spp. (8,000 EUR), TB in those ≥ 16 years of age (5,300 EUR) and syphilis (1,150 EUR). States with extended screening had per capita costs 2.84 times those of states that exclusively screened for TB in asylum seekers ≥ 16 years of age (p < 0.0001, 95% confidence interval (CI): 1.96–4.10). Screening practices in Germany entailed high costs; evidence-based approaches to infectious disease screening are needed. European Centre for Disease Prevention and Control (ECDC) 2017-10-05 /pmc/articles/PMC5710125/ /pubmed/29019315 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.40.16-00677 Text en This article is copyright of The Authors, 2017. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Research Article
Bozorgmehr, Kayvan
Wahedi, Katharina
Noest, Stefan
Szecsenyi, Joachim
Razum, Oliver
Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015
title Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015
title_full Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015
title_fullStr Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015
title_full_unstemmed Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015
title_short Infectious disease screening in asylum seekers: range, coverage and economic evaluation in Germany, 2015
title_sort infectious disease screening in asylum seekers: range, coverage and economic evaluation in germany, 2015
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710125/
https://www.ncbi.nlm.nih.gov/pubmed/29019315
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.40.16-00677
work_keys_str_mv AT bozorgmehrkayvan infectiousdiseasescreeninginasylumseekersrangecoverageandeconomicevaluationingermany2015
AT wahedikatharina infectiousdiseasescreeninginasylumseekersrangecoverageandeconomicevaluationingermany2015
AT noeststefan infectiousdiseasescreeninginasylumseekersrangecoverageandeconomicevaluationingermany2015
AT szecsenyijoachim infectiousdiseasescreeninginasylumseekersrangecoverageandeconomicevaluationingermany2015
AT razumoliver infectiousdiseasescreeninginasylumseekersrangecoverageandeconomicevaluationingermany2015